The IMMP1L Knockout SK-HEP-1 Polyclonal Cells product is a CRISPR/Cas9-edited polyclonal knockout cell population in which the IMMP1L gene has been disrupted. This loss-of-function model is generated in the SK-HEP-1 human hepatocellular carcinoma cell line, yielding a heterogeneous pool of edited cells. The polyclonal format avoids clonal selection artifacts and preserves genetic diversity, making it suitable for functional genomic studies and population-level analyses. This ready-to-use product accelerates gene function studies in a liver cancer background without the need for in-house editing.
SK-HEP-1 cells are a hepatic epithelial line derived from a human liver adenocarcinoma. They are extensively employed in hepatocellular carcinoma research, particularly for investigating cancer metabolism, drug response, and mitochondrial biology. Their tumorigenic origin and retention of hepatic characteristics make them a valuable model for studying liver cancer pathogenesis and metabolic reprogramming. These cells offer a robust in vitro system for mechanistic studies and high-throughput applications in liver cancer biology.
IMMP1L encodes the catalytic subunit of the inner membrane peptidase (IMP) complex, which proteolytically processes nuclear-encoded mitochondrial proteins during import. The IMP complex, formed by IMMP1L and IMMP2L, cleaves mitochondrial targeting sequences from precursors such as cytochrome c1 and other respiratory chain subunits. Its activity is regulated by PGC-1?? and mitochondrial biogenesis signals, and it is essential for the assembly of functional respiratory chain complexes and oxidative phosphorylation. Disruption of IMMP1L impairs precursor maturation, leading to defective mitochondrial respiration and altered cellular metabolism.
In the SK-HEP-1 hepatocellular carcinoma context, IMMP1L knockout provides a model to interrogate the consequences of impaired mitochondrial protein processing in liver cancer. Hepatocellular carcinoma cells often exhibit metabolic flexibility, and loss of IMMP1L may exacerbate reliance on glycolysis or trigger stress pathways. This model facilitates investigation into mitochondrial dysfunction, apoptosis resistance, and the role of post-import protein maturation in tumor biology. It also enables the study of how mitochondrial deficits influence cancer progression and drug sensitivity.
These polyclonal knockout cells are applicable to diverse research areas including mitochondrial biology, protein trafficking, cancer metabolism, and drug target validation. Representative assays include western blotting for precursor protein accumulation, respirometry to measure oxygen consumption, mitochondrial import assays, RT-qPCR for metabolic gene expression, and immunofluorescence for mitochondrial morphology. The cells can also be used for apoptosis and cell viability studies. For further information or to discuss customization, please contact Ascent Research.
